Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma
Clinical trial NCT00210366 · TERMINATED
Trial details
- NCT number
- NCT00210366
- Sponsor
- International Extranodal Lymphoma Study Group (IELSG)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2010-07-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.